344 related articles for article (PubMed ID: 29044707)
1. The Effect of Vitamin D Supplementation on Bone Metabolic Markers in Chronic Kidney Disease.
Yadav AK; Kumar V; Kumar V; Banerjee D; Gupta KL; Jha V
J Bone Miner Res; 2018 Mar; 33(3):404-409. PubMed ID: 29044707
[TBL] [Abstract][Full Text] [Related]
2. High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial.
Alvarez JA; Law J; Coakley KE; Zughaier SM; Hao L; Shahid Salles K; Wasse H; Gutiérrez OM; Ziegler TR; Tangpricha V
Am J Clin Nutr; 2012 Sep; 96(3):672-9. PubMed ID: 22854402
[TBL] [Abstract][Full Text] [Related]
3. Effect of vitamin D supplementation on serum sclerostin levels in chronic kidney disease.
Yadav AK; Kumar V; Banerjee D; Gupta KL; Jha V
J Steroid Biochem Mol Biol; 2018 Jun; 180():15-18. PubMed ID: 29331722
[TBL] [Abstract][Full Text] [Related]
4. Cholecalciferol Supplementation Promotes Bone Turnover in Chinese Adults with Vitamin D Deficiency.
Yao P; Sun L; Xiong Q; Xu X; Li H; Lin X
J Nutr; 2018 May; 148(5):746-751. PubMed ID: 29897564
[TBL] [Abstract][Full Text] [Related]
5. Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study.
Chandra P; Binongo JN; Ziegler TR; Schlanger LE; Wang W; Someren JT; Tangpricha V
Endocr Pract; 2008; 14(1):10-7. PubMed ID: 18238736
[TBL] [Abstract][Full Text] [Related]
6. Cholecalciferol supplementation and angiogenic markers in chronic kidney disease.
Kaur J; Kamboj K; Yadav AK; Kaur P; Kumar V; Jha V
PLoS One; 2022; 17(6):e0268946. PubMed ID: 35657784
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Long-Term Cholecalciferol Supplementation on Vascular Calcification in Chronic Kidney Disease Patients With Hypovitaminosis D.
Samaan F; Carvalho AB; Pillar R; Rocha LA; Cassiolato JL; Cuppari L; Canziani MEF
J Ren Nutr; 2019 Sep; 29(5):407-415. PubMed ID: 30686750
[TBL] [Abstract][Full Text] [Related]
8. Cholecalciferol, Calcitriol, and Vascular Function in CKD: A Randomized, Double-Blind Trial.
Kendrick J; Andrews E; You Z; Moreau K; Nowak KL; Farmer-Bailey H; Seals DR; Chonchol M
Clin J Am Soc Nephrol; 2017 Sep; 12(9):1438-1446. PubMed ID: 28784657
[TBL] [Abstract][Full Text] [Related]
9. Effect of isolated vitamin D supplementation on bone turnover markers in younger postmenopausal women: a randomized, double-blind, placebo-controlled trial.
Nahas-Neto J; Cangussu LM; Orsatti CL; Bueloni-Dias FN; Poloni PF; Schmitt EB; Nahas EAP
Osteoporos Int; 2018 May; 29(5):1125-1133. PubMed ID: 29450585
[TBL] [Abstract][Full Text] [Related]
10. Impact of cholecalciferol treatment on biomarkers of inflammation and myocardial structure in hemodialysis patients without hyperparathyroidism.
Bucharles S; Barberato SH; Stinghen AEM; Gruber B; Piekala L; Dambiski AC; Custodio MR; Pecoits-Filho R
J Ren Nutr; 2012 Mar; 22(2):284-291. PubMed ID: 21908203
[TBL] [Abstract][Full Text] [Related]
11. Cholecalciferol supplementation increases FGF23 in peritoneal dialysis patients with hypovitaminosis D: a randomized clinical trial.
Ramirez-Sandoval JC; Arvizu-Hernandez M; Cruz C; Vazquez-Cantu B; Rojas-Concha LJ; Tamez L; Reynerio F; Gomez FE; Correa-Rotter R
J Nephrol; 2019 Aug; 32(4):645-659. PubMed ID: 30888584
[TBL] [Abstract][Full Text] [Related]
12. A Randomized Trial of Vitamin D Supplementation on Vascular Function in CKD.
Kumar V; Yadav AK; Lal A; Kumar V; Singhal M; Billot L; Gupta KL; Banerjee D; Jha V
J Am Soc Nephrol; 2017 Oct; 28(10):3100-3108. PubMed ID: 28667080
[TBL] [Abstract][Full Text] [Related]
13. Impact of treatment with active vitamin D calcitriol on bone turnover markers in people with type 2 diabetes and stage 3 chronic kidney disease.
Stathi D; Fountoulakis N; Panagiotou A; Maltese G; Corcillo A; Mangelis A; Ayis S; Gnudi L; Karalliedde J
Bone; 2023 Jan; 166():116581. PubMed ID: 36216304
[TBL] [Abstract][Full Text] [Related]
14. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
15. Randomized Controlled Trial for the Effect of Vitamin D Supplementation on Vascular Stiffness in CKD.
Levin A; Tang M; Perry T; Zalunardo N; Beaulieu M; Dubland JA; Zerr K; Djurdjev O
Clin J Am Soc Nephrol; 2017 Sep; 12(9):1447-1460. PubMed ID: 28550081
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of cholecalciferol and calcitriol on calcium metabolism and bone turnover in Chinese postmenopausal women with vitamin D insufficiency.
Zhang H; Huang QR; Gu JM; Hu WW; Liu YJ; Hu YQ; Zhang ZL
Acta Pharmacol Sin; 2012 Apr; 33(4):490-5. PubMed ID: 22407227
[TBL] [Abstract][Full Text] [Related]
17. Influence of vitamin D supplementation on bone mineral content, bone turnover markers, and fracture risk in South African schoolchildren: multicenter double-blind randomized placebo-controlled trial (ViDiKids).
Middelkoop K; Micklesfield LK; Walker N; Stewart J; Delport C; Jolliffe DA; Mendham AE; Coussens AK; van Graan A; Nuttall J; Tang JCY; Fraser WD; Cooper C; Harvey NC; Hooper RL; Wilkinson RJ; Bekker LG; Martineau AR
J Bone Miner Res; 2024 Apr; 39(3):211-221. PubMed ID: 38477739
[TBL] [Abstract][Full Text] [Related]
18. Early renal impairment affects hormonal regulators of calcium and bone metabolism and Wnt signalling and the response to vitamin D supplementation in healthy older adults.
Christodoulou M; Aspray TJ; Piec I; Washbourne C; Tang JCY; Fraser WD; Schoenmakers I;
J Steroid Biochem Mol Biol; 2023 May; 229():106267. PubMed ID: 36739953
[TBL] [Abstract][Full Text] [Related]
19. Effect of 16-weeks vitamin D replacement on calcium-phosphate homeostasis in overweight and obese adults.
Mesinovic J; Mousa A; Wilson K; Scragg R; Plebanski M; de Courten M; Scott D; Naderpoor N; de Courten B
J Steroid Biochem Mol Biol; 2019 Feb; 186():169-175. PubMed ID: 30367939
[TBL] [Abstract][Full Text] [Related]
20. Cholecalciferol Supplementation Attenuates Bone Loss in Incident Kidney Transplant Recipients: A Prespecified Secondary Endpoint Analysis of a Randomized Controlled Trial.
Tsujita M; Doi Y; Obi Y; Hamano T; Tomosugi T; Futamura K; Okada M; Hiramitsu T; Goto N; Isaka Y; Takeda A; Narumi S; Watarai Y
J Bone Miner Res; 2022 Feb; 37(2):303-311. PubMed ID: 34747516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
